Safety, tolerability, pharmacokinetics and pharmacodynamics of HRS-1893 in patients with obstructive hypertrophic cardiomyopathy: a randomized, double-blind, placebo-controlled phase 1 trial
Event: ESC Congress 2025
Topic: Hypertrophic Cardiomyopathy
Session: Advancing care in hypertrophic cardiomyopathy
